Dr. David Samadi is SMART About Prostate Cancer

After leaving Iran at the age of 15, Dr. David Samadi is living the American dream. Despite having to leave the country and his parents behind so he and his younger brother could get an education that the war-torn country of Iran could not provide at the time. The two began their lives as immigrants in the country of Belgium before moving to England and eventually settling in the United States where Dr. David Samadi finished his high school and college education.

His academic success in the United States began in Roslyn, New York where as an honor roll student he became the class president. After graduating high school Dr. David Samadi earned a degree in biochemistry at Stony Brook University before earning his medical degree at the Stony Brook School of Medicine in 1994. From there he completed fellowships and additional training at Montefiore Medical Center, the Albert Einstein College of Medicine, and Memorial Sloan Kettering Cancer Center. Quite possibly the most important part of his post-graduate education came at Henri Mondor Hospital in France where groundbreaking work involving robotics was taking place in concern to radical prostatectomies. His mentor at the hospital, Professor Claude Abbou, was the first in the world to perform a prostatectomy with the aid of the da Vinci robot that he had borrowed from the cardiology department at the hospital.

Throughout Dr. David Samadi’s career, he has performed thousands of robotic-assisted radical prostatectomies, almost 8,000. His success rate as a surgeon that treats prostate cancer is almost unheard of and one of the best in the world with an 89% chance of his patients being completely free of prostate cancer after the operation. Dr. David Samadi even created his own technique for the surgery using the da Vinci robot that he learned on at the Henri Mondor Medical Center known as SMART, the Samadi Modified Advanced Robotic Technique. This technique is quite popular among his patients as it prevents many of the complications related to the surgery by preserving the nerves before the prostate is removed. The fear of complications is why many patients that have been diagnosed with prostate cancer choose to put it off, sometimes with devastating results. Recently, Dr. David Samadi was interviewed about his opinion on the results of Mitt Romney’s prostatectomy in 2017. He believes that his choice of surgery over radiation may have saved his life as the success rate is much higher.

Dr. David Samadi’s Facebook Page: www.facebook.com/DrDavidSamadi/

Bringing Robotics to the Forefront: Dr. David Samadi

If you are involved in the field of robotic surgery, then you have probably heard the name Dr. David Samadi. Dr. Samadi is one of the foremost doctors in his field of urology, and he has been helping patients cope with and defeat prostate cancer for the past several years. Dr. David Samadi has been helping to pioneer a new type of surgery aimed at removing cancer cells in a less invasive and more precise way. With the help of robotic instruments, this new treatment for prostate cancer surgery has helped thousands of men get back on their feet and remain cancer free for the rest of their lives.

One of prostate cancer’s most recent victims was the Presidential nominee and Utah Senator Mitt Romney. Diagnose dearly in 2017, Romney did not know where to turn. His doctor had given him several options, including radiation therapy and traditional surgery. He knew the risks that traditional surgery posed, and he wanted another answer. He found robotic surgery and decided that was the way he wanted to remove his illness. Romney underwent surgery in 2017 and he has been cancer-free ever since. Not only is he cancer free, but he was back up and working in a minimal amount of time and did not lose any of his bodily functions during the surgery. For that, he can thank Dr. Samadi.

Dr. Samadi came to the United States after fleeing from his hometown in Iran during the Iranian Revolution in 1979. Wanting to make his parents proud, he became what he had always wanted to be: a doctor. Samadi found his true calling during a surgery observation one day. While he was scheduled to watch a cardiac surgery, a patient getting a prostatectomy was brought in. He was intrigued by how challenging the surgery looked, and he knew this was what he wanted to do. He graduated from the State University of New York with his Master’s degree and Montefiore Medical Center with his MD. He was ready to take on the world.

Dr. David Samadi worked at several hospitals an in several programs, including the Henri Mondor Hospital Robotic Radical Prostatectomy program in France, the proctology training program at the Albert Einstein College of Medicine, and a fellowship at the Memorial Sloan-Kettering Cancer Center. He served as the Chairman of the Urology Department at Mount Saini Hospital, and he is currently the Chair of the Urology Department and the Chief of Robotic Surgery at Lenox Hill Hospital in New York.

Inside the Mind of Dr.David Samadi

Dr. David Samadi is a Urologist at the head of his field, always searching for the newest frontiers in medicine. He began his search at the early age of 15 in Iran. With the Iranian Revolution of 1979, he had to leave his home country for Belgium and London, where he continued Dr. David Samadi’s education. He completed high school in the United States, however, and attended Stony Brook University to attain a degree in Biochemistry — without paying a single cent of tuition thanks to a full scholarship. Dr.David Samadi would stay at Stony Brook University to acquire his M.D. then go to MonteFiore Medical School for postgraduate training. The urologist went on to refine his talents at Albert Einstein College of Medicine.

Dr. David Samadi’s biggest accomplishments are in the realm of telesurgery. He created the Samadi Modified Advanced Robotic Technique, abbreviated as SMART, which is a precise method of robotic surgery used to cure people who have prostate cancer. His method has a success rate of 90% if the cancer is detected early. And unlike other forms of prostate surgery, which require large incisions that can potentially damage the prostate nerves that control sexual function as well as bladder control, Dr.David Samadi’s technique barely leaves a trace. It’s because of this that the prestigious Urologist believes robotics are the future of the medical field. He talks about this and more in an interview at Lenox Hill Hospital.

The interview begins with a casual tone as Dr.David Samadi talks about his origins. He says he always wanted to be a doctor growing up in order to help others, but wasn’t really invested in the idea until robotic surgery was invented. Robotic surgery appears to have propelled his career later on in life as well. Dr.Samadi says that training with French Urologists using laparoscopic technology helped him make important career advances when he returned to America. He also talks about some of his daily habits in the interview. Waking up early, being compassionate to his peers, and maintaining a positive outlook are some of the habits he maintains throughout his day-to-day life. They’re all traits that appear to have brought Dr.David Samadi to where he is today, as a Chairman of Urology at Lenox Hill Hospital.

For details: health.usnews.com/doctors/david-samadi-3908

Eric Lefkofsky, his Charities, and the Success of Tempus

Although Eric Lefkofsky is very much involved in philanthropic activities, much of his attention has been given to creating, buying, and the selling of companies. He is currently worth an estimated $1.65 billion and is still involved in quite a few businesses. His newest startup is called, Tempus. When his wife, Liz, was diagnosed with breast cancer, he realized the doctors needed to research their data on the results of their treatments more carefully.

It was difficult for the doctors and researchers to analyze the results of past treatments, because of the privacy issues related to their patients. So, what Tempus does, is to take the personal information from each file and ensure that the doctors and researchers only analyze files without names or addresses. This allows everyone to share information with one another, making treatment plans for their cancer patients much more targeted for positive results than in the past. Lefkofsky hopes to see research companies, such as, CRISPR use the technology of Tempur in ways that might further their research faster.

Achieving his law degree from the University of Michigan, Mr Lefkofsky worked hard selling carpets as a freshman in college. He and his business partner, Bradley Keywell, borrowed enough money to buy Brandon Apparel, in 1994, but it went under and lawsuits followed. In 1999, they started an internet company called, Starbelly, which they were able to sell for $240 million. Lefkofsky is currently involved with Tempus, Lightbank, Groupon, Uptake Technologies, Mediaocean, Echo Global Logistics, and InnerWorkings. Click here to know more.

Along with his wife Liz, Lefkofsky donates much of his time and money to charitable causes, such as, art, culture, education, early childhood development, science, technology, and human rights. Together, they started a foundation called, the Lefkofsky Family Foundation, which focuses much of their contributions to the Chicago area in which they live. They have a strong urge to contribute to programs and research globally as well.